Patents Assigned to STAIDSON (BEIJING) PHARMACEUTICAL CO., LTD
  • Transgenic rodents having NGF beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins
    Patent number: 8487157
    Abstract: Transgenic rodents having NGF beta gene mutants in their genomes express NGF beta mutant proteins. The preparation methods of the transgenic rodents, the methods of utilizing the transgenic animals to prepare NGF beta mutant proteins and the resulting NGF beta mutant proteins are provided. The transgenic rodents are useful in preparing human NGF and in the study of the functions of NGF beta mutants and their receptors in the whole animal level, and also useful for screening and purifying NGF beta mutants which have high activity and high security.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: July 16, 2013
    Assignee: Staidson (Beijing) Pharmaceutical Co., Ltd.
    Inventors: Zhiwen Zhou, Hongshan Zhang, Hongbo Chen
  • TRANSGENIC RODENTS HAVING NGF BETA GENE MUTANTS AND ITS PREPARATION METHODS, THE PREPARATION METHODS OF THE CORRESPONDING MUTANT PROTEINS AND THE RESULTING MUTANT PROTEINS
    Publication number: 20110082285
    Abstract: Transgenic rodents having NGF beta gene mutants in their genomes express NGF beta mutant proteins. The preparation methods of the transgenic rodents, the methods of utilizing the transgenic animals to prepare NGF beta mutant proteins and the resulting NGF beta mutant proteins are provided. The transgenic rodents are useful in preparing human NGF and in the study of the functions of NGF beta mutants and their receptors in the whole animal level, and also useful for screening and purifying NGF beta mutants which have high activity and high security.
    Type: Application
    Filed: March 7, 2008
    Publication date: April 7, 2011
    Applicant: STAIDSON (BEIJING) PHARMACEUTICAL CO., LTD
    Inventors: Zhiwen Zhou, Hongshan Zhang, Hongbo Chen